Sector
PharmaceuticalsOpen
₹0.84Prev. Close
₹0.87Turnover(Lac.)
₹4.85Day's High
₹0.85Day's Low
₹0.852 Week's High
₹1.4452 Week's Low
₹0.83Book Value
₹1.59Face Value
₹1Mkt Cap (₹ Cr.)
33.88P/E
17.4EPS
0.05Divi. Yield
020 Jan 2025
12:00 AM
Board Meeting
Agenda : Audited Result
13 Sep 2024
12:00 AM
BookCloser
13 Sep 2024
12:00 AM
AGM
Announcement Date: 13 Sep, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 39.86 | 39.86 | 19.93 | 19.93 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 23.12 | 22.49 | 40.39 | 37.86 |
Net Worth | 62.98 | 62.35 | 60.32 | 57.79 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 17.21 | 2.47 | 7.85 | 8.53 |
yoy growth (%) | 596.07 | -68.52 | -7.95 | 302.84 |
Raw materials | -16.32 | -1.57 | -3.36 | -4.02 |
As % of sales | 94.86 | 63.69 | 42.82 | 47.1 |
Employee costs | -0.07 | -0.06 | -0.09 | -0.09 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.7 | 0.23 | 3.5 | 3.73 |
Depreciation | 0 | 0 | 0 | 0 |
Tax paid | -0.11 | 0 | 0 | 0 |
Working capital | -2.04 | 3.52 | 1.27 | 6.3 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 596.07 | -68.52 | -7.95 | 302.84 |
Op profit growth | 198.22 | -93.21 | -6.89 | 469.93 |
EBIT growth | 199.31 | -93.24 | -6.91 | 504.15 |
Net profit growth | 34.31 | -93.26 | -6.23 | 592.39 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,744.85 | 132.89 | 4,18,647.96 | 1,181.05 | 0.77 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 6,001.1 | 76.85 | 1,59,310.35 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,478.5 | 25.66 | 1,19,409.63 | 1,438.15 | 0.88 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,137.55 | 58.21 | 1,06,184.18 | 485 | 0.89 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,413.35 | 51.49 | 99,569.64 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
Sombir Singh
Non Executive Director
Kishan Nityanand Naidu
Company Sec. & Compli. Officer
Namita Acharya
Independent Director
Harshadkumar Rathod
Chairman & Wholetime Director
Aman Patel
Non Executive Director
Amrutaben Solanki
Independent Director
Nimeshkumar Parmar
Independent Director
Harshadkumar Rathod
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Shree Ganesh Biotech India Ltd
Summary
Shree Ganesh Biotech India Limited was incorporated on September 2, 1982, as S.P. Commercial Co. Limited under the Registrar of Companies, West Bengal. The Company has got the Certificate of Commencement of Business on September 14, 1982 from the Registrar of Companies, West Bengal. The Company was incorporated with an object to carry on the business of builders, Contractors and to deal in property and also to do investment and finance business.In 2010, pursuant to a Scheme of Amalgamation, Shree Ganesh Bio-Tech (India) Private Limited was merged with S.P. Commercial Co. Limited pursuant to the order of the Honble High at Calcutta dated February 15, 2010. The entire business of Shree Ganesh Bio-Tech (India) Private Limited consisting of trading and distribution of seeds were transferred to S.P. Commercial Co. Limited. Subsequently, Shree Ganesh Bio-Tech (India) Private Limited was dissolved pursuant to the said Scheme of Amalgamation and the name of the Company was changed to Shree Ganesh Bio-Tech (India) Limited. The name of the Company was changed to Shree Ganesh Bio-Tech (India) Limited and a fresh Certificate of Incorporation upon the change of name dated March 7, 2011 was issued by the Registrar of Companies, West Bengal.The Company is presently engaged in the business of production, processing and marketing of high quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum, etc.
Read More
What is the Shree Ganesh Biotech India Ltd share price today?
The Shree Ganesh Biotech India Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹0.85 today.
What is the Market Cap of Shree Ganesh Biotech India Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Shree Ganesh Biotech India Ltd is ₹33.88 Cr. as of 09 May ‘25
What is the PE and PB ratio of Shree Ganesh Biotech India Ltd?
The PE and PB ratios of Shree Ganesh Biotech India Ltd is 17.4 and 0.55 as of 09 May ‘25
What is the 52 Week High and Low of Shree Ganesh Biotech India Ltd?
The 52-week high/low is the highest and lowest price at which a Shree Ganesh Biotech India Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Shree Ganesh Biotech India Ltd is ₹0.83 and ₹1.44 as of 09 May ‘25
What is the CAGR of Shree Ganesh Biotech India Ltd?
Shree Ganesh Biotech India Ltd's CAGR for 5 Years at -32.93%, 3 Years at -37.48%, 1 Year at -25.00%, 6 Month at -17.92%, 3 Month at -18.69% and 1 Month at -5.43%.
What is the shareholding pattern of Shree Ganesh Biotech India Ltd?
The shareholding pattern of Shree Ganesh Biotech India Ltd is as follows:
Promoters - 0.00 %
Institutions - 1.42 %
Public - 98.58 %
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
